Letter to EditorAutoimmune hemolytic anemia, COVID-19, and the importance of a complete immunohematologic evaluation
Section snippets
Funding
No funding was received.
Declaration of competing interest
The author has no conflicts of interest.
References (7)
- et al.
Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting
Blood Rev
(2020) - et al.
Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID- 19
Blood
(2020) - et al.
Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: a case report
J Infect Chemother
(2023)
There are more references available in the full text version of this article.
Cited by (0)
© 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.